Abbott expands Navitor TAVI system indication in Europe
Abbott has received CE mark approval in Europe for an expanded indication of its Navitor™ transcatheter aortic valve implantation (TAVI) system, significantly broadening treatment options for patients with symptomatic, severe aortic stenosis. The minimally invasive device is now approved for patients at low or intermediate surgical risk, complementing its existing approval for high and extreme-risk […]
